Antidote Technologies, developer of a recruitment platform for clinical trials, has agreed an $11m round that will be led by Merck Global Health Innovation Fund.

University of Geneva spinout Amal Therapeutics has added $9.6m to its coffers following a series B round backed by Boehringer Ingelheim and Helsinn.

Daimler and Deutsche Bahn have celebrated an exit as Madsack Mediengruppe acquired CleverShuttle.

The PFR NCBR CVC Fund of Funds will put a total of $225m into corporate venturing units set up by domestic and overseas companies to stimulate the ecosystem.

Cambridge Innovation Capital has led a series A round for Prowler.io, which uses artificial intelligence to predict complex interactions in dynamic systems.